| Clinical data | |
|---|---|
| Other names | Lysergylvaline amide; N-Lysergylvalylamide; N-((1S)-1-(aminocarbonyl)-2-methylpropyl)-9,10-didehydro-6-methylergoline-8β-carboxamide |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H26N4O2 |
| Molar mass | 366.465 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ergovalide, also known as lysergylvaline amide or as N-lysergylvalylamide, is an ergot alkaloid of the lysergamide family found in Claviceps purpurea (ergot). It is said to constitute about 10 to 20% of the alkaloid content of ergot. However, according to a secondary source, ergovalide is probably a chemical artifact arising from solvolytic cleavage of ergocristine (lysergylvalylphenylalanylproline) (which is a highly variable constituent but can constitute as much as 50% of alkaloids in ergot). Ergovalide was first described in the scientific literature by A. N. Ban'kovskaya and colleagues in 1973.
Ergocristine was the predominant alkaloid accounting for half of the total alkaloids in all grain types. This study documented that barley, rye, triticale and wheat collected across Western Canada had similar percentages of ergocornine (6±1%, P=0.201), ergocristine (48±2%, P=0.939), ergocryptine (17±2%, P=0.302) and ergosine (5±0.5%, P=0.239).